Therapeutic strategies for congenital myasthenic syndromes
To date, more than 25 genes have been implicated in the etiology of the congenital myasthenic syndromes (CMS), and an ever-growing phenotypic landscape is now encountered in the CMS clinic. Unlike the autoimmune form of myasthenia, there is no role for immunomodulatory agents in the treatment of CMS...
Príomhchruthaitheoirí: | Lee, M, Beeson, D, Palace, J |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Wiley
2018
|
Míreanna comhchosúla
Míreanna comhchosúla
-
The congenital myasthenic syndromes.
de réir: Palace, J, et al.
Foilsithe / Cruthaithe: (2008) -
Congenital myasthenic syndromes.
de réir: Beeson, D, et al.
Foilsithe / Cruthaithe: (1997) -
Congenital myasthenic syndromes: an update.
de réir: Finlayson, S, et al.
Foilsithe / Cruthaithe: (2013) -
Congenital myasthenic syndromes and the neuromuscular junction.
de réir: Cruz, P, et al.
Foilsithe / Cruthaithe: (2014) -
The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
de réir: Rodríguez Cruz, P, et al.
Foilsithe / Cruthaithe: (2018)